Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 May;73(5):1970-8.
doi: 10.1002/mrm.25313. Epub 2014 Jun 20.

Imaging mouse lung allograft rejection with (1)H MRI

Affiliations
Comparative Study

Imaging mouse lung allograft rejection with (1)H MRI

Jinbang Guo et al. Magn Reson Med. 2015 May.

Abstract

Purpose: To demonstrate that longitudinal, noninvasive monitoring via MRI can characterize acute cellular rejection in mouse orthotopic lung allografts.

Methods: Nineteen Balb/c donor to C57BL/6 recipient orthotopic left lung transplants were performed, further divided into control-Ig versus anti-CD4/anti-CD8 treated groups. A two-dimensional multislice gradient-echo pulse sequence synchronized with ventilation was used on a small-animal MR scanner to acquire proton images of lung at postoperative days 3, 7, and 14, just before sacrifice. Lung volume and parenchymal signal were measured, and lung compliance was calculated as volume change per pressure difference between high and low pressures.

Results: Normalized parenchymal signal in the control-Ig allograft increased over time, with statistical significance between day 14 and day 3 posttransplantation (0.046→0.789; P < 0.05), despite large intermouse variations; this was consistent with histopathologic evidence of rejection. Compliance of the control-Ig allograft decreased significantly over time (0.013→0.003; P < 0.05), but remained constant in mice treated with anti-CD4/anti-CD8 antibodies.

Conclusion: Lung allograft rejection in individual mice can be monitored by lung parenchymal signal changes and by lung compliance through MRI. Longitudinal imaging can help us better understand the time course of individual lung allograft rejection and response to treatment.

Keywords: MRI; acute cellular rejection; compliance; lung transplant.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Experimental plan
Fig. 2
Fig. 2. Schematic of ventilation and MRI acquisition
Fig. 3
Fig. 3
(a) Representative axial 1H MR images (TE = 0.954 ms, flip angle = 20°) of a control-Ig treated mouse at POD 3, POD 7 and POD 14 (in-slice allograft [left lung] lung signal: 0.043, 0.077 and 0.701 respectively; allograft compliance: 0.010, 0.005 and 0.001 in cc/cm H2O respectively), and one corresponding histological slice (H & E, 200×) of the allograft at POD 14. (b) Corresponding 1H MR images and histological slice (H & E, 200×) of an anti-CD4/anti-CD8 treated mouse (allograft signal: 0.045, 0.049 and 0.042 respectively; allograft compliance: 0.015, 0.017 and 0.016 in cc/cm H2O respectively). Rejection is visually apparent in the control-Ig treated allograft at POD 14, though signal increases slightly at POD 7.
Fig. 3
Fig. 3
(a) Representative axial 1H MR images (TE = 0.954 ms, flip angle = 20°) of a control-Ig treated mouse at POD 3, POD 7 and POD 14 (in-slice allograft [left lung] lung signal: 0.043, 0.077 and 0.701 respectively; allograft compliance: 0.010, 0.005 and 0.001 in cc/cm H2O respectively), and one corresponding histological slice (H & E, 200×) of the allograft at POD 14. (b) Corresponding 1H MR images and histological slice (H & E, 200×) of an anti-CD4/anti-CD8 treated mouse (allograft signal: 0.045, 0.049 and 0.042 respectively; allograft compliance: 0.015, 0.017 and 0.016 in cc/cm H2O respectively). Rejection is visually apparent in the control-Ig treated allograft at POD 14, though signal increases slightly at POD 7.
Fig. 4
Fig. 4
Mean parenchymal signal (mean ± SD) of control-Ig treated and anti-CD4/anti-CD8 treated mice as percent of mean soft-tissue signal at POD 3, POD 7 and POD 14. We note that the anti-CD4/anti-CD8 treated allograft signal increases at POD 7 & POD 14, which we believe results from edema and/or atelectasis in the transplanted lung in mouse 217 at POD 7 and mouse 278 at POD 14. aP = 0.04 compared to POD 3, allograft, control-Ig. bP = 0.04 compared to POD 14, allograft, control-Ig.
Fig. 5
Fig. 5
Compliance (mean ± SD) of control-Ig treated and anti-CD4/anti-CD8 treated mice at 3 timepoints. aP < 0.05 compared to POD 3, allograft, control-Ig. bP = 0.04 compared to POD 3, native lung, anti-CD4/anti-CD8. cP < 0.05 compared to allograft, anti-CD4/anti-CD8, at POD 7 and POD 14 respectively.
Fig. 6
Fig. 6
An array of histological slides from 2 anti-CD4/anti-CD8 treated and 1 control-Ig treated mice demonstrating (a) some residual edema and cellular consolidation, (c) resolution of POD 7 edema, (e) near-complete consolidation & rejection, and (b, d, f) corresponding control, native lungs (H & E, 100×).
Fig. 7
Fig. 7
Negative correlation between the volume percentage of high-intensity signal in the allografts and allograft compliance.

Similar articles

Cited by

References

    1. Kotloff RM, Thabut G. Lung transplantation. Am J Respir Crit Care Med. 2011;184(2):159–171. - PubMed
    1. Christie JD, Edwards LB, Kucheryavaya AY, et al. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant. 2012;31(10):1073–1086. - PubMed
    1. Belperio JA, Weigt SS, Fishbein MC, Lynch JP., 3rd Chronic lung allograft rejection: Mechanisms and therapy. Proc Am Thorac Soc. 2009;6(1):108–121. - PubMed
    1. Todd JL, Palmer SM. Bronchiolitis obliterans syndrome: The final frontier for lung transplantation. Chest. 2011;140(2):502–508. - PubMed
    1. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc. 2009;6(1):54–65. - PMC - PubMed

Publication types

MeSH terms